Serum cardiac troponin-T concentrations predict development of coronary artery disease in heart transplant patients

Transplantation

Volumn 66, Issue 10, 1998, Pages 1335-1339

  Faulk, W Page ^a   Labarrere, Carlos A ^a   Torry, Ronald J ^a   Nelson, David R ^a  

^a METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN T;

ADULT; ALLOGRAFT; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT FAILURE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; REPERFUSION INJURY; VASCULAR ENDOTHELIUM;

EID: 0032573421     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199811270-00013     Document Type: Article

References (36)

1. Katus HA, Looser S, Hallermayer K, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992; 38: 386.
2. Gerhardt W, Katus HA, Ravkilde J, Hamm CW. S-troponin-T as a marker of ischemic myocardial injury. Clin Chem 1992; 38: 1194.
3. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin-T in patients admitted with unstable angina. Br Med J 1996; 313: 262.
4. Mair J, Dienstl F, Puschendorf B. Cardiac troponin-T in the diagnosis of myocardial injury. Crit Rev Clin Lab Sci 1992; 29: 31.
5. Lindahl B, Venge P, Wallentin L. Relation between troponin-T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651.
6. St Goar FG, Pinto FJ, Alderman EL, et al. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of "angiographically silent" intimal thickening. Circulation 1992; 85: 979.
7. Labarrere CA, Nelson DR, Faulk WP. Endothelial activation and development of coronary artery disease in transplanted human hearts. JAMA 1997; 278: 1169.
8. Faulk WP, Labarrere CA, Nelson DR, Pitts D. Hemostasis, fibrinolysis and natural anticoagulation in transplant vascular sclerosis. J Heart Lung Transplant 1995; 14: S158.
9. Labarrere CA, Pitts D, Nelson DR, Faulk WP. Vascular tissue plasminogen activator and the development of coronary artery disease in heart transplant recipients. N Engl J Med 1995; 333: 1111.
10. Faulk WP, Labarrere CA, Nelson DR, Pitts D. Coronary artery disease in cardiac allografts: association with arterial anti-thrombin. Transplant Proc 1995; 27: 1944.
11. Gaudin PB, Rayburn BK, Hutchins GM, et al. Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Surg Pathol 1994; 18: 338.
12. Yilmaz S, Paavonen T, Hayry P. Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology. Transplantation 1992; 53: 823.
13. Land W, Schneeberger H, Schleibner S, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211.
14. Day JD, Rayburn BK, Gaudin PB, et al. Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury. J Heart Lung Transplant 1995; 14: S142.
15. Labarrere CA, Nelson DR, Faulk WP. Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients. Am J Med 1998; 105: 207.
16. Carrier M, Solymoss BC, Cartier R, Leclerc Y, Pelletier LC. Cardiac troponin-T and creatine kinase MB isoenzyme as biochemical markers of ischemia after heart preservation and transplantation. J Heart Lung Transplant 1994; 13: 696.
17. Katus HA, Schoeppenthau M, Tanzeem A, et al. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin-T. Br Heart J 1991; 65: 259.
18. Mair J, Wieser C, Seibt I, et al. Troponin-T to diagnose myocardial infarction in bypass surgery. Lancet 1991; 337: 434.
19. Billingham ME, Cary NRB, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group; International Society for Heart Transplantation. J Heart Transplant 1990; 9: 587.
20. Faulk WP, Labarrere CA. Fibrinolytic and anticoagulant control of hemostasis in human cardiac and renal allografts. Major Prob Pathol 1994; 30: 49.
21. Lipshultz SE, Rifai N, Sallan SE, et al. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation 1997; 96: 2641.
22. Hopkins KA. Basic microlymphocytotoxicity test. In: Zachary AA, Teresi GA, eds. ASHI laboratory manual, 2nd Ed. Cleveland: American Society for Histocompatibility and Immunogenetics, 1990; 195.
23. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
24. Faulk WP, Labarrere CA, Pitts D, Halbrook H. Vascular lesions in specimens devoid of cellular infiltrates: qualitative and quantitative studies of human cardiac allografts. J Heart Lung Transplant 1993; 12: 219.
25. Crowley J, Hu M. Covariance analysis of heart transplant survival. J Am Statist Assoc 1977; 72: 27.
26. Manly BJF. Randomization and Monte Carlo methods in biology, 1st Ed. London: Chapman and Hall, 1991.
27. Stark RP, McGinn AL, Wilson RF. Chest pain in cardiac-transplant recipients. Evidence of sensory reinnervation after cardiac transplantation. N Engl J Med 1991; 324: 1791.
28. Gao SZ, Schroeder JS, Hunt SA, Billingham ME, Valantine HA, Stinson EB. Acute myocardial infarction in cardiac transplant recipients. Am J Cardiol 1989; 64: 1093.
29. Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987; 76: 827.
30. Bajaj S, Shah A, Crandall C, et al. Coronary collateral circulation in the transplanted heart. Circulation 1993; 88 (part 2): II 263.
31. Johnson TH, Das GS, McGinn AL, Christensen BV, Meyer SM, Wilson RF. Physiologic assessment of the coronary collateral circulation in transplanted human hearts. J Heart Lung Transplant 1994; 13: 840.
32. Torry RJ, Labarrere CA, Torry DS, Holt VJ, Faulk WP. Vascular endothelial growth factor expression in transplanted human hearts. Transplantation 1995; 60: 1451.
33. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843.
34. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 1996; 270: H1803.
35. Pearlman JD, Hibberd MG, Chaung ML, et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1995; 1: 1085.
36. 165 in patients with ischaemic limb. Lancet 1996; 348: 370.